LSO has completed Aptocine treatment in a Phase 3 trial in hepatocellular carcinoma and in a Phase 3 trial in colorectal cancer metastatic to the liver. LSO has also completed treatment in a Phase 1 and Phase 2 clinical trials in benign prostatic hyperplasia (BPH).
For additional information, contact info@lsoncology.com.